Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; Specially H5N1 and H9N2

Molecular Biology Reports

Volumn 37, Issue 6, 2010, Pages 2909-2914

  Ebrahimi, Seyyed Mahmoud ^a   Tebianian, Majid ^a   Aghaiypour, Khosrow ^a   Nili, Hassan ^b   Mirjalili, Ali ^a  

^a RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

^b SHIRAZ UNIVERSITY   (Iran)

Author keywords

Avian influenza; Expression; M2 protein; pAED4; SDS PAGE

Indexed keywords

ANTISERUM; INFLUENZA VACCINE; PROTEIN ANTIBODY; PROTEIN M2; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS RNA; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN;

ANIMAL CELL; ANTIGENICITY; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; CELL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; IRAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROKARYOTIC CELL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; QUALITATIVE ANALYSIS; SEQUENCE ALIGNMENT; VIRUS ISOLATION; VIRUS STRAIN; WESTERN BLOTTING; ANIMAL; BIRD; CELL LINE; DOG; FLUORESCENT ANTIBODY TECHNIQUE; GENE VECTOR; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; INFLUENZA IN BIRDS; METABOLISM; VIROLOGY; VIRUS GENE;

ANIMALS; BIRDS; CELL LINE; DOGS; FLUORESCENT ANTIBODY TECHNIQUE; GENES, VIRAL; GENETIC VECTORS; IMMUNOBLOTTING; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; PROKARYOTIC CELLS; VACCINES, SYNTHETIC; VIRAL MATRIX PROTEINS;

AVES; INFLUENZA A VIRUS; ORYCTOLAGUS CUNICULUS; PROKARYOTA;

EID: 77955659571     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9851-5     Document Type: Article

References (20)

1. + T cells can promote survival and recovery after challenge Int Immunol 12 91 101 10.1093/intimm/12.1.91 1:CAS:528:DC%2BD3cXotVKltg%3D%3D 10607754
2. JB Ulmer JJ Donnelly SE Parker GH Rhodes PL Felgner VJ Dwarki SH Gromkowski RR Deck CM DeWitt A Friedman 1993 Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 1745 1749 10.1126/science.8456302 1:CAS:528:DyaK3sXitFSqtrk%3D 8456302 (Pubitemid 23114660)
3. SL Epstein TM Tumpey JA Misplon CY Lo LA Cooper K Subbarao M Renshaw S Sambhara JM Katz 2002 DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice Emerg Infect Dis 8 796 801 1:CAS:528:DC%2BD38Xms1Cqurk%3D 12141964
4. SL Zebedee RA Lamb 1988 Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virion J Virol 62 2762 2772 1:CAS:528:DyaL1cXltVOmt7s%3D 2455818
5. SM Ebrahimi K Aghaiypour H Nili 2008 Sequence analysis of M2 gene of avian influenza virus strain (A/chicken/Iran/101/98 (H9N2)) as an oil vaccine seed Iran J Biotechnol 6 4 235 238 1:CAS:528:DC%2BD1MXjtFCrurs%3D
6. J Fan X Liang MS Horton HC Perry MP Citron GJ Heidecker TM Fu J Joyce CT Przysiecki PM Keller VM Garsky R Ionescu Y Rippeon L Shi MA Chastain 2004 Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys Vaccine 22 2993 3003 10.1016/j.vaccine.2004.02.021 1:CAS:528:DC%2BD2cXmsVCqsbc%3D 15297047 (Pubitemid 39037199)
7. VA Slepushkin JM Katz RA Black WC Gamble PA Rota NJ Cox 1995 Protection of mice against influenza A virus challenge by vaccination with baculovirus- expressed M2 protein Vaccine 13 1399 1402 10.1016/0264-410X(95)92777-Y 1:CAS:528:DyaK2MXpvF2itL0%3D 8578816
8. AM Frace AI Klimov T Rowe RA Black JM Katz 1999 Modified M2 proteins produce heterotypic immunity against influenza A virus Vaccine 17 2237 2244 10.1016/S0264-410X(99)00005-5 1:CAS:528:DyaK1MXjs1ejsLc%3D 10403591 (Pubitemid 29225675)
9. S Neirynck T Deroo X Saelens P Vanlandschoot WM Jou W Fiers 1999 A universal influenza V vaccine based on the extracellular domain of the M2 protein Nat Med 5 1157 1163 10.1038/13484 1:CAS:528:DyaK1MXms1Wktrg%3D 10502819 (Pubitemid 29474420)
10. K Mozdzanowska J Feng M Eid G Kragol M Cudic JL Otvos W Gerhard 2003 Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2 Vaccine 21 2616 2626 10.1016/S0264-410X(03)00040-9 1:CAS:528:DC%2BD3sXjs1Wlt7o%3D 12744898 (Pubitemid 36561354)
11. K Okuda A Ihata S Watabe E Okada T Yamakawa K Hamajima J Yang N Ishii M Nakazawa K Okuda K Ohnari K Nakajima KQ Xin 2001 Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene Vaccine 19 3681 3691 10.1016/S0264-410X(01)00078-0 1:CAS:528: DC%2BD3MXktV2htLs%3D 11395202 (Pubitemid 32522766)
12. S Watabe K-Q Xin A Ihata L-J Liu A Honsho I Aoki K Hamajima B Wahren K Okuda 2001 Protection against influenza virus challenge by topical application of influenza DNA vaccine Vaccine 19 4434 4444 10.1016/S0264-410X(01)00194-3 1:CAS:528:DC%2BD3MXlsFylsLw%3D 11483269 (Pubitemid 32718667)
13. K Martin A Helenius 1991 Transport of incoming influenza virus nucleocapsids into the nucleus J Virol 65 232 244 1:CAS:528:DyaK3MXjvFSgsQ%3D%3D 1985199
14. M De Filette W Min Jou A Birkett K Lyons B Schultz A Tonkyro S Resch W Fiers 2005 Universal influenza A vaccine: optimization of M2-based constructs Virology 337 1 149 161 10.1016/j.virol.2005.04.004 15914228 (Pubitemid 40725448)
15. BE Johansson TM Moran CA Bona SW Popple ED Kilbourne 1987 Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience J Immunol 139 6 2010 2014 1:STN:280:DyaL2szgvFyhtA%3D%3D 3624874
16. BE Johansson ED Kilbourne 1993 Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition J Virol 67 10 5721 5723 1:CAS:528:DyaK3sXms1yntr0%3D 8371337
17. K Mozdzanowska J Feng M Eid G Kragol M Cudic LJ Otvos W Gerhard 2003 Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2 Vaccine 21 19-20 2616 2626 10.1016/S0264-410X(03)00040-9 1:CAS:528:DC%2BD3sXjs1Wlt7o%3D 12744898 (Pubitemid 36561354)
18. J Andrea S Nicole S Tazio FB Martin 2004 Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity J Immunol 172 5598 5605
19. RA Lamb CJ Lai PW Choppin 1981 Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: Colinear and interrupted mRNAs code for overlapping proteins Proc Natl Acad Sci 78 7 4170 4174 10.1073/pnas.78.7.4170 1:CAS:528:DyaL3MXlvF2hsro%3D 6945577 (Pubitemid 11010301)
20. SL Zebedee CD Richardson RA Lamb 1985 Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA J Virol 56 2 502 511 1:CAS:528:DyaL2MXlvFSksrk%3D 3840537